Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/LY-367,265> ?p ?o }
Showing triples 1 to 58 of
58
with 100 triples per page.
- LY-367,265 abstract "LY-367,265 is a drug developed by Eli Lilly, which acts as both a potent and selective antagonist at the serotonin 5-HT2A receptor, and also a selective serotonin reuptake inhibitor (SSRI). It has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine.".
- LY-367,265 casNumber "210751-39-6".
- LY-367,265 iupacName "1-(2-(4-(6-fluoro-1H-indol-3-yl)-5,6-dihydropyridin-1(2H)-yl)ethyl)-1,4,5,6-tetrahydro-[1,2,5]thiadiazolo[4,3,2-ij]quinoline 2,2-dioxide".
- LY-367,265 pubchem "4605800".
- LY-367,265 thumbnail LY-367265_structure.png?width=300.
- LY-367,265 wikiPageID "40779105".
- LY-367,265 wikiPageLength "3049".
- LY-367,265 wikiPageOutDegree "12".
- LY-367,265 wikiPageRevisionID "702437289".
- LY-367,265 wikiPageWikiLink 5-HT2A_receptor.
- LY-367,265 wikiPageWikiLink Antidepressant.
- LY-367,265 wikiPageWikiLink Category:5-HT2A_antagonists.
- LY-367,265 wikiPageWikiLink Category:Eli_Lilly_and_Company.
- LY-367,265 wikiPageWikiLink Category:Selective_serotonin_reuptake_inhibitors.
- LY-367,265 wikiPageWikiLink Eli_Lilly_and_Company.
- LY-367,265 wikiPageWikiLink Glutamic_acid.
- LY-367,265 wikiPageWikiLink Morphine.
- LY-367,265 wikiPageWikiLink Receptor_(biochemistry).
- LY-367,265 wikiPageWikiLink Receptor_antagonist.
- LY-367,265 wikiPageWikiLink Selective_serotonin_reuptake_inhibitor.
- LY-367,265 wikiPageWikiLink Serotonin.
- LY-367,265 wikiPageWikiLinkText "LY-367,265".
- LY-367,265 c "24".
- LY-367,265 casNumber "210751".
- LY-367,265 f "1".
- LY-367,265 h "25".
- LY-367,265 iupacName "1".
- LY-367,265 molecularWeight "452.54".
- LY-367,265 n "4".
- LY-367,265 o "2".
- LY-367,265 pubchem "4605800".
- LY-367,265 s "1".
- LY-367,265 smiles "FC1=CC=C2C=C1".
- LY-367,265 width "260".
- LY-367,265 wikiPageUsesTemplate Template:Drugbankcite.
- LY-367,265 wikiPageUsesTemplate Template:Drugbox.
- LY-367,265 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- LY-367,265 wikiPageUsesTemplate Template:Reflist.
- LY-367,265 wikiPageUsesTemplate Template:Serotonergics.
- LY-367,265 subject Category:5-HT2A_antagonists.
- LY-367,265 subject Category:Eli_Lilly_and_Company.
- LY-367,265 subject Category:Selective_serotonin_reuptake_inhibitors.
- LY-367,265 hypernym Drug.
- LY-367,265 type ChemicalSubstance.
- LY-367,265 type Drug.
- LY-367,265 type ChemicalObject.
- LY-367,265 type Thing.
- LY-367,265 type Q8386.
- LY-367,265 comment "LY-367,265 is a drug developed by Eli Lilly, which acts as both a potent and selective antagonist at the serotonin 5-HT2A receptor, and also a selective serotonin reuptake inhibitor (SSRI). It has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine.".
- LY-367,265 label "LY-367,265".
- LY-367,265 sameAs Q15409397.
- LY-367,265 sameAs m.0y7xb_j.
- LY-367,265 sameAs LY-367,265.
- LY-367,265 sameAs LY-367,265.
- LY-367,265 sameAs Q15409397.
- LY-367,265 wasDerivedFrom LY-367,265?oldid=702437289.
- LY-367,265 depiction LY-367265_structure.png.
- LY-367,265 isPrimaryTopicOf LY-367,265.